STRONGBRIDGE BIOPHARMA plc Intangible Assets, Net (Including Goodwill)
STRONGBRIDGE BIOPHARMA plc had Intangible Assets, Net (Including Goodwill) of $24.83 million as of 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Notes › Goodwill and Other
us-gaap:IntangibleAssetsNetIncludingGoodwill · last filed 2021-08-05
- 2021-06-30: Intangible Assets, Net (Including Goodwill) $24.83M.
- 2021-03-31: Intangible Assets, Net (Including Goodwill) $26.09M.
- 2020-12-31: Intangible Assets, Net (Including Goodwill) $27.34M.
- 2020-09-30: Intangible Assets, Net (Including Goodwill) $28.60M.
| Period end | Intangible Assets, Net (Including Goodwill) |
|---|---|
| 2021-06-30 | $24.83M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $26.09M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $27.34M 10-Q · filed 2021-08-05 |
| 2020-09-30 | $28.60M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $29.86M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $31.11M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $32.37M 10-K · filed 2021-03-03 |
| 2019-09-30 | $33.62M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $34.88M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $36.13M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $37.39M 10-K · filed 2021-03-03 |
| 2018-09-30 | $61.72M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $63.42M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $65.30M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $42.41M 10-K · filed 2020-02-28 |
| 2017-09-30 | $43.67M 6-K · filed 2017-11-14 |
| 2017-06-30 | $65.64M 6-K · filed 2017-08-07 |
| 2017-03-31 | $66.90M 6-K · filed 2017-05-16 |
| 2016-12-31 | $68.16M 10-K · filed 2019-02-27 |
| 2016-09-30 | $38.58M 6-K · filed 2016-12-30 |
| 2016-06-30 | $38.58M 6-K · filed 2016-12-30 |
| 2015-12-31 | $43.81M 10-K · filed 2018-03-12 |
| 2014-12-31 | $7.43M 20-F · filed 2017-04-04 |
| 2013-12-31 | $7.43M 20-F · filed 2016-03-24 |